These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31671452)

  • 1. Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
    Novak RT; Ronveaux O; Bita AF; Aké HF; Lessa FC; Wang X; Bwaka AM; Fox LM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S279-S285. PubMed ID: 31671452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.
    Patel JC; Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Lingani C; Hatcher C; Acosta AM; Thomas JD; Diomande F; Martin S; Clark TA; Mihigo R; Hajjeh RA; Zilber CH; Aké F; Mbaeyi SA; Wang X; Moisi JC; Ronveaux O; Mwenda JM; Novak RT;
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S148-S154. PubMed ID: 31671453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
    Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
    Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
    Mustapha MM; Harrison LH
    Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
    Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
    Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
    Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
    Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
    Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    Diallo AO; Soeters HM; Yameogo I; Sawadogo G; Aké F; Lingani C; Wang X; Bita A; Fall A; Sangaré L; Ouédraogo-Traoré R; Medah I; Bicaba B; Novak RT;
    PLoS One; 2017; 12(11):e0187466. PubMed ID: 29095907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.
    Borrow R; Caugant DA; Ceyhan M; Christensen H; Dinleyici EC; Findlow J; Glennie L; Von Gottberg A; Kechrid A; Vázquez Moreno J; Razki A; Smith V; Taha MK; Tali-Maamar H; Zerouali K;
    J Infect; 2017 Jul; 75(1):1-11. PubMed ID: 28455205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa.
    Sambo L; Chan M; Davis S; Lake A; Berkley S; Poonawalla C; Elias CJ
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S387-8. PubMed ID: 26553663
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Case-Based Meningitis Surveillance in 5 Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
    Mbaeyi SA; Lingani C; Diallo AO; Bicaba B; Ouédraogo-Traoré R; Acyl M; Gamougame K; Coulibaly O; Coulibaly S; Zaneidou M; Sidikou F; Nikiema C; Sadji AY; Aké F; Tarbangdo F; Sakande S; Tall H; Njanpop-Lafourcade BM; Moïsi J; N'diaye A; Bwaka A; Bita A; Fernandez K; Poy A; Soeters HM; Vuong J; Novak R; Ronveaux O;
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S155-S164. PubMed ID: 31671451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.